Responding to developments | Cutting through the noise | Promoting diverse voices | Shaping opinion | Making connections | Pointing to the evidence

BSAC launches community-focused initiative in response to ‘global emergency’ of superbugs

18th November 2020

Building on the success of its Antibiotic Action campaign (which began in 2012), the British Society for Antimicrobial Chemotherapy (BSAC) has today launched a global health initiative called Stop Superbugs.

Spreading the word about superbugs: why we need to think outside the box when it comes to the AMR message

10th November 2020

Antibiotic resistant infections, or ‘superbugs’, are one of the gravest threats we face. They already cause more than 750,000 deaths every year - or around one person every 40 seconds. Yet despite the scale of the issue, recognition remains low, especially amongst the general public. In this post, Edwin Panford-Quainoo explores how scientists, academics and health professionals can do more to spread the message about drug-resistant infections.

Plummeting number of UTI diagnoses since the advent of COVID brings huge uncertainty to the management of serious infections in vulnerable patients

4th November 2020

Urinary tract infections (UTIs) cause misery to millions every year, with around half of all women experiencing at least one UTI in their lifetime. Usually, they are simple to treat. Clinicians prescribe antibiotics empirically whilst awaiting the results of a urine culture. Yet the disruption to primary care caused by the SARS-CoV-2 pandemic has given rise to some troubling trends...

New report calls for major breakthrough in efforts to deliver OPAT services across the NHS

2nd November 2020

BSAC is delighted to endorse the recommendations of the Transforming NHS Pharmacy Aseptic Services in England review.

NIHR Funding Call: improving antifungal stewardship in haemato-oncology patients using a biomarker directed strategy.

2nd November 2020

Invasive fungal disease (IFD) remains a significant cause of morbidity and mortality in adult and paediatric haemato-oncology patients.

UTIs and AMR: How wee can stem the rise of drug resistant superbugs

27th October 2020

Up to 1.2 million women in Britain suffer from chronic – long-term – lower urinary tract (UTI) infections. Every year, UTIs are responsible for 184,000 unplanned hospital admissions, which cost the NHS around £434m to treat. Yet all too often, these infections are treated with broad-spectrum antibiotics, which only treat the symptoms not the underlying causes. In this post, Giovanna Forte, CEO of Forte Medical, talks about her own experiences with a chronic UTI infection, and the simple solution she hopes can bring relief to all...

BSAC Paediatric Common Infection Pathways open for consultation

19th October 2020

Draft Paediatric Common Infections Pathways are now available for public consultation.

Aspergillosis: how environment pollution helped transform a fungal infection into a drug-resistant superbug

13th October 2020

When we talk about superbugs, much of the focus tends to be on drug-resistant bacterial infections. Yet the drugs we use to treat fungal infections are also beginning to fail, with devastating implications for our health. In this post, Jill Fairweather from the Aspergillosis Trust talks about how a ‘hidden’ fungal infection is already impacting patients’ lives and how environmental pollution is making a bad situation even worse...

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?